Lydus Medical, founded in 2017 and headquartered in Israel, is a pioneering start-up in the Health Care industry. The company's innovative system, Vesseal™, automated microvascular suturing device, is set to revolutionize microsurgery by automating the creation of a safe, simple, and fast anastomosis for ultra-small vessels. The recent milestone for Lydus Medical was the successful closure of a $2.70M Seed Round, which took place on 24 May 2021. The investment saw participation from notable investors including GlenRock Capital, Mor Research Applications, Sanara Ventures, EuroUS Ventures, and Technion - Israel Institute of Technology. Lydus Medical's cutting-edge technology and support from prominent investors signal great potential for the company's future in advancing microsurgery and shaping the future of medical innovation.
No recent news or press coverage available for Lydus Medical.